Call for Papers

Advances in Synthetic Biology

Special issue in SLAS Technology – abstracts accepted until December 1, 2022!

Submit Proposal

SLAS Technology Guest Editor Shue Wang, Ph.D., invites the submission of abstracts on advances in synthetic biology for publication in a Special Issue. Wang is seeking high-quality, short-or full-length research reports, reviews, protocols and perspectives related to synthetic cell systems, gene circuits, cell-free expression systems, RNA regulation, metabolic engineering and nucleic acid engineering. Manuscripts are welcome from academia, industry, and vendors. Areas of particular interest include, but are not limited to:

  • Synthetic cell systems (protocells, artificial cell system)
  • Cell-free expression systems (Transcription-translation [TXTL])
  • Genetic circuit design and optimization
  • Metabolic engineering (design, construction, and optimization of native and non-natural routes of product synthesis)
  • RNA regulation (programming microRNA, mRNA in mammalian cells)
  • Computation methods for genetic system design
  • Nucleic acid engineering
  • Synthetic biology approaches in infectious diseases

Submit your proposal before December 1, 2022.  

All submitted papers will be subject to peer-review to ensure scientific rigor, clarity of expression and integration with other contributions in the SLAS Technology Special Issue.

Publication note: After submissions are accepted, they publish online within 30 days and become immediately searchable and citable with a DOI. 

Questions? Please e-mail ajump@slas.org or call +1.630.256.7527, ext. 106.

AI and Automation (A2) in Multiplexing Cellular and Tissue Imaging

Special issue in SLAS Technology – manuscripts accepted until March 1, 2023!

Submit Manuscript 

SLAS Technology Guest Editors Joe Yeong, (Group Leader Singapore General Hospital), Loo Lit-Hsin, (Senior PI, Bioinformatic Institute, A*STAR), and Colt Egelston, (Assistant Research Professor, City of Hope National Medical Center), invite the submission of abstracts relating to AI and Automation (A2) in cellular and tissue imaging for publication in a 2023 Special Issue.

SLAS Technology is seeking high-quality, short- or full-length research reports, reviews, and perspectives related to AI and Automation (A2) in cellular and tissue imaging. This includes the A2 perspectives of multiplex IHC/IF, spatial transcriptomics & proteomics, high-throughput screening, cell painting and other relevant topics. Manuscripts are welcome from academia, industry, and vendors. Areas of particular interest include: 

  • Analytic pipeline and algorithm of multiplex imaging assays 
  • Automation, standardization and upscaling the throughput of multiplex imaging assays 
  • High-dimensional analysis of multiplex imaging assays  
  • Biomarkers discovery by using multiplex imaging assays 
  • Spatial information of tumor immune micro-environment by using multiplex imaging assays 
  • Immuno-phenotyping by using multiplex imaging assays
  • Technical reproducibility of multiplex imaging assays
  • Comparison of multiplex imaging assays with other modalities such as conventional IHC, RNAseq, NanoString
  • Comparison of two or more multiplex imaging assays techniques (e.g. DNA barcoding vs fluorescence vs metal-conjugation) 
  • Clinical application and translation of biomarkers with multiplex imaging assays

Submit your manuscript before March 1, 2023.  

All submitted papers will be subject to peer-review to ensure scientific rigor, clarity of expression and integration with other contributions in the SLAS Technology Special Issue.

Publication note: After submissions are accepted, they are typically published online ahead-of-print within 30 days and become immediately searchable and citable with a DOI. 

Questions? Please e-mail ajump@slas.org or call +1.630.256.7527, ext. 106.

Now Offering APC Waivers for Review Articles – Limited Time Only

Publication fees waived through August 31!

Submit in SLAS Discovery Submit in SLAS Technology


The editors of SLAS Discovery and SLAS Technology are currently seeking review articles on a variety of novel and current drug discovery topics. Reviews are essential contributions to the SLAS research community, serving to educate, improving the accessibility of research and providing authors with an opportunity to authoritatively distill the latest research advances. Review authors benefit from higher citations and distribution, while readers benefit from a filtered and condensed survey of complex topics.

For a limited time, the publication fee will be waived upon acceptance for all reviews submitted by August 31. For a full rundown on acceptable review manuscripts and submission criteria, visit our SLAS Journals Manuscript Category Descriptions and Examples page.

Review articles are a cumulative overview of the results from a collection of journal references about a particular topic. Existing materials, such as the introductory section of a thesis, can often be built into successful review articles by graduate students and postdoctoral researchers.

Reviews must be completed and submitted by August 31 to receive publication fee waivers. All submitted papers will be subject to peer-review to ensure scientific rigor, clarity of expression and integration with other contributions in the SLAS Discovery and SLAS Technology journals.

Questions? Please e-mail ajump@slas.org or call +1.630.256.7527, ext. 106.

SLAS Discovery: Now Accepting Protocols

Completed Manuscripts accepted until August 31!

Submit Protocol Manuscript

SLAS Discovery is pleased to introduce a new Protocols article type (see article type details in our Guide for Authors). In summary, the intent is to focus on step-by-step descriptions of methods that enable scientists across academia and industry to directly reproduce the protocol and adapt it to their research needs.

Methods published as part of a full research article often lack sufficient detail necessary to easily recreate the experiment(s) and analysis. To address this gap, SLAS Discovery Protocols now allow authors to publish these methods in full detail, thereby providing much-needed reproducibility and rigor of methods. To inaugurate the release of Protocols, we have devoted a Special Issue to the novel format. In the future, Protocols will be a standard article type for SLAS Discovery and will be published Open Access.

SLAS Discovery Guest Editor(s) Mariafrancesca Scalise, Ph.D. (University of Calabria) and Adam Zweifach, Ph.D. (University of Connecticut) invite the submission of validated experimental protocols for publication in a 2022 Special Issue. Manuscript proposals (abstracts) will be used to select and invite protocols for review and publication consideration.

Drs. Scalise and Zweifach seek high-quality and validated protocols on methods that have been previously used in published and peer-reviewed scientific studies. Protocols not used previously will only be considered if experimental data demonstrating the feasibility and efficacy of the method is submitted. Abstracts are welcome from academia, industry and service providers. Methods will need to be in scope with the Journal and include, but are not limited to:

  • High-throughput transfection protocols of primary or stem cells
  • Primary screening of primary cells, e.g., endocrine, cancer, neuroscience targets
  • Automated cultivation of cells, stem cells, organoids and other 3D models, including lab-on-a-chip
  • Methods enabling exploration of biology in 3D
  • High-throughput/high-content imaging and image analysis
  • Data analysis and/or computational protocols for high-throughput/high-content screening data, including deep learning and AI approaches
  • Detailed screening assay methodology for identifying novel targets (e.g., CRISPR, si/shRNA) or compounds
  • Target validation protocols
  • Target engagement protocols
  • High-throughput/high-content methods for v5ADME/PK/toxicology
  • Methods for identification and validation (preclinical and/or clinical) of target relevant biomarkers, including gene expression, e.g., fluorescent in situ hybridization.
  • Allosteric modulators of kinases, GPCRs, NHRs, etc., protacs and degraders

All submitted papers will be subject to peer-review to ensure scientific rigor, clarity of expression and integration with other contributions in the SLAS Discovery Special Issue.

Publication note: After submissions are accepted, articles publish online ahead-of-print within 30 days, becoming immediately searchable and citable with a DOI.

Questions? Please e-mail ajump@slas.org or call +1.630.256.7527, ext. 106.

SLAS Discovery Call for Papers: Protease Drug Discovery

Completed Manuscripts accepted until October 31!

Submit Protease Manuscript

SLAS Discovery Guest Editors Jon Ellery, Ph.D. and Nicholas Bland, Ph.D., invite the submission of manuscripts on topics around protease drug discovery for publication in a 2023 Special Issue.

Drs. Ellery and Bland seek high-quality, short- or full-length research reports, reviews and perspectives related to any aspect of the development of therapeutics directed towards proteases. Abstracts are welcome from academia, industry, and vendors.

Areas of particular interest include, but are not limited to:

  • Protease kinetics and its application to protease drug discovery, including approaches such as single-molecule kinetics.
  • Moving beyond activity assays, for example by utilizing approaches such as biophysics (SPR, GCI, MST, second harmonic generation, etc.) for hit identification, characterization and small molecule optimization for targeting proteases. 
  • New approaches to enzyme directed therapeutics, including modulating non-enzymatic functions of proteases, enzyme activation, biologics, PROTACs, etc.
  • Structure-guided approaches to protease directed drug discovery including computational methodologies as well as experimental techniques including but not limited to X-ray crystallography, NMR and cryo-EM.
  • Examples of successful protease drug discovery efforts that forge a path into new therapeutic areas and what innovations were used to make this happen.
  • Perspectives on the developing landscape of protease drug discovery and the key challenges that are limiting our ability to bring effective therapeutics to the clinic.

Manuscripts selected for invitation will need to be completed and submitted by August 15. All submitted papers will be subject to peer-review to ensure scientific rigor, clarity of expression and integration with other contributions in the SLAS Discovery Special Issue.

Publication note: After submissions are accepted, articles publish online ahead-of-print within 30 days, becoming immediately searchable and citable with a DOI.

Questions? Please e-mail ajump@slas.org or call +1.630.256.7527, ext. 106.

SLAS Technology Call for Papers: Bioprinting the Future

Special issue proposals accepted until December 15!

Submit Proposal

SLAS Technology Guest Editor(s) Prof. Roman Voronov, Ph.D., and Murat Guvendiren, Ph.D., from the Departments of Chemical and Materials Engineering, and Biomedical Engineering, at the New Jersey Institute of Technology, invite the submission of abstracts about novel advances and applications in bioprinting for publication in a 2023 Special Issue. SLAS Technology has a 3.047 2020 Impact Factor (3.124 5-Year Impact Factor) and selected authors participating in the Special Issue will have their Open Access fee waived. Manuscript proposals (abstracts) will be used to select and invite papers for review and publication consideration. 

Dr(s). Voronov and Guvendiren seek high-quality, short- or full-length research reports, reviews, and perspectives related to novel advances and applications in bioprinting. Manuscript proposals (abstracts) are welcome from academia, industry, and vendors. Areas of particular interest include, but are not limited to: 

  • Bioprinter Instrumentation & Innovative Technologies (e.g., 4D bioprinting)
  • Bioprinting Methods & Strategies 
  • Bioinks & Materials for 3D Printing 
  • Bioprinted Tissues & Organs 
  • Bioprinted Disease Models 
  • Bioprinting In Situ/In Vivo 
  • Bioprinting Applications (e.g., Printing in Space) 
  • Analysis of Bioprinted Constructs 
  • Mathematical Modeling of Bioprinting Processes 

Submit your manuscript proposal before August 15. It should include your name, contact information, affiliation, a working title, and abstract (250-500 words) as an MS Word document. 

Abstract proposals will be evaluated to invite full manuscript submissions. Invited manuscripts will need to be completed and submitted by November 15. All submitted papers will be subject to peer-review to ensure scientific rigor, clarity of expression and integration with other contributions in the SLAS Technology Special Issue.  

Publication note: After submissions are accepted, they typically publish online ahead-of-print within 30 days and become immediately searchable and citable with a DOI.  

Questions? Please e-mail ajump@slas.org or call +1.630.256.7527, ext. 106.